These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 12504817)

  • 1. What happens when cardiac Na channels lose their function? 1--numerical studies of the vulnerable period in tissue expressing mutant channels.
    Starmer CF; Colatsky TJ; Grant AO
    Cardiovasc Res; 2003 Jan; 57(1):82-91. PubMed ID: 12504817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What happens when cardiac Na channel function is compromised? 2. Numerical studies of the vulnerable period in tissue altered by drugs.
    Starmer CF; Grant AO; Colatsky TJ
    Cardiovasc Res; 2003 Mar; 57(4):1062-71. PubMed ID: 12650884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New aspects of vulnerability in heterogeneous models of ventricular wall and its modulation by loss of cardiac sodium channel function.
    Kapela A; Tsoukias N; Bezerianos A
    Med Biol Eng Comput; 2005 May; 43(3):387-94. PubMed ID: 16035228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proarrhythmic response to potassium channel blockade. Numerical studies of polymorphic tachyarrhythmias.
    Starmer CF; Romashko DN; Reddy RS; Zilberter YI; Starobin J; Grant AO; Krinsky VI
    Circulation; 1995 Aug; 92(3):595-605. PubMed ID: 7634474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of skeletal but not cardiac Na+ channel isoform preserves normal conduction in a depolarized cardiac syncytium.
    Protas L; Dun W; Jia Z; Lu J; Bucchi A; Kumari S; Chen M; Cohen IS; Rosen MR; Entcheva E; Robinson RB
    Cardiovasc Res; 2009 Feb; 81(3):528-35. PubMed ID: 18977767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A proarrhythmic response to sodium channel blockade: modulation of the vulnerable period in guinea pig ventricular myocardium.
    Nesterenko VV; Lastra AA; Rosenshtraukh LV; Starmer CF
    J Cardiovasc Pharmacol; 1992 May; 19(5):810-20. PubMed ID: 1381780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ischemic modulation of vulnerable period and the effects of pharmacological treatment of ischemia-induced arrhythmias: a simulation study.
    Cimponeriu A; Starmer CF; Bezerianos A
    IEEE Trans Biomed Eng; 2003 Feb; 50(2):168-77. PubMed ID: 12665030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ionic Mechanisms of Impulse Propagation Failure in the FHF2-Deficient Heart.
    Park DS; Shekhar A; Santucci J; Redel-Traub G; Solinas S; Mintz S; Lin X; Chang EW; Narke D; Xia Y; Goldfarb M; Fishman GI
    Circ Res; 2020 Dec; 127(12):1536-1548. PubMed ID: 32962518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sodium channel (dys)function and cardiac arrhythmias.
    Remme CA; Bezzina CR
    Cardiovasc Ther; 2010 Oct; 28(5):287-94. PubMed ID: 20645984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic control of sodium channel function.
    Tan HL; Bezzina CR; Smits JP; Verkerk AO; Wilde AA
    Cardiovasc Res; 2003 Mar; 57(4):961-73. PubMed ID: 12650874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conditional knockout of Fgf13 in murine hearts increases arrhythmia susceptibility and reveals novel ion channel modulatory roles.
    Wang X; Tang H; Wei EQ; Wang Z; Yang J; Yang R; Wang S; Zhang Y; Pitt GS; Zhang H; Wang C
    J Mol Cell Cardiol; 2017 Mar; 104():63-74. PubMed ID: 28119060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computer simulation of wild-type and mutant human cardiac Na+ current.
    Vecchietti S; Rivolta I; Severi S; Napolitano C; Priori SG; Cavalcanti S
    Med Biol Eng Comput; 2006 Mar; 44(1-2):35-44. PubMed ID: 16929919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular basis of ranolazine block of LQT-3 mutant sodium channels: evidence for site of action.
    Fredj S; Sampson KJ; Liu H; Kass RS
    Br J Pharmacol; 2006 May; 148(1):16-24. PubMed ID: 16520744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel Brugada syndrome-causing mutation in ion-conducting pore of cardiac Na+ channel does not affect ion selectivity properties.
    Amin AS; Verkerk AO; Bhuiyan ZA; Wilde AA; Tan HL
    Acta Physiol Scand; 2005 Dec; 185(4):291-301. PubMed ID: 16266370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Azithromycin Causes a Novel Proarrhythmic Syndrome.
    Yang Z; Prinsen JK; Bersell KR; Shen W; Yermalitskaya L; Sidorova T; Luis PB; Hall L; Zhang W; Du L; Milne G; Tucker P; George AL; Campbell CM; Pickett RA; Shaffer CM; Chopra N; Yang T; Knollmann BC; Roden DM; Murray KT
    Circ Arrhythm Electrophysiol; 2017 Apr; 10(4):. PubMed ID: 28408648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The variant hERG/R148W associated with LQTS is a mutation that reduces current density on co-expression with the WT.
    Mechakra A; Vincent Y; Chevalier P; Millat G; Ficker E; Jastrzebski M; Poulin H; Pouliot V; Chahine M; Christé G
    Gene; 2014 Feb; 536(2):348-56. PubMed ID: 24334129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potassium channel blockade amplifies cardiac instability numerical studies of torsades de pointes.
    Starmer CF; Reddy MR; Namasivayam A; Singh M
    Indian J Physiol Pharmacol; 1994 Oct; 38(4):259-66. PubMed ID: 7883289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long QT syndrome, Brugada syndrome, and conduction system disease are linked to a single sodium channel mutation.
    Grant AO; Carboni MP; Neplioueva V; Starmer CF; Memmi M; Napolitano C; Priori S
    J Clin Invest; 2002 Oct; 110(8):1201-9. PubMed ID: 12393856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sodium channels, cardiac arrhythmia, and therapeutic strategy.
    Miller D; Wang L; Zhong J
    Adv Pharmacol; 2014; 70():367-92. PubMed ID: 24931202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms by which SCN5A mutation N1325S causes cardiac arrhythmias and sudden death in vivo.
    Tian XL; Yong SL; Wan X; Wu L; Chung MK; Tchou PJ; Rosenbaum DS; Van Wagoner DR; Kirsch GE; Wang Q
    Cardiovasc Res; 2004 Feb; 61(2):256-67. PubMed ID: 14736542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.